Goldman Sachs
CLB icon

Goldman Sachs’s Core Laboratories CLB Stock Holding History

Goldman Sachs’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-100
Closed -$15K – 6566
2013
Q2 		$15K Buy
+100
New +$14.2K ﹤0.01% 6214

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's CLB Position: Q1 2026 in Review

Goldman Sachs increased its Core Laboratories (CLB) stake by 0.43% in Q1 2026, buying an estimated $65.3K and bringing the position to 848,901 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2764.

Goldman Sachs first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q3 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Goldman Sachs held 848,901 shares of Core Laboratories worth $14.3M as of Q1 2026.
  • Goldman Sachs bought 3,650 Core Laboratories shares in Q1 2026, an estimated $65.3K.
  • Core Laboratories made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2764 holding.
  • Goldman Sachs first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Core Laboratories position peaked at $103M in Q3 2014.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.